147 related articles for article (PubMed ID: 12868125)
41. Replacement therapy and cardiovascular diseases.
Boschetti M; Goglia U; Teti C; Esposito D; Giusti M; Minuto F; Ferone D
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):85-90. PubMed ID: 19020394
[TBL] [Abstract][Full Text] [Related]
42. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
43. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
[TBL] [Abstract][Full Text] [Related]
44. Adult growth hormone deficiency (GHD): an established diagnosis?
Attanasio AF
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):27-32. PubMed ID: 19020382
[TBL] [Abstract][Full Text] [Related]
45. Effect of GH treatment on bone mass in children with GH deficiency.
Baroncelli GI; Saggese G
J Endocrinol Invest; 2005; 28(10 Suppl):23-7. PubMed ID: 16550718
[TBL] [Abstract][Full Text] [Related]
46. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults: a double-blind, placebo-controlled, crossover, short-term trial followed by long-term open GH replacement in hypopituitary adults.
Sverrisdóttir YB; Elam M; Caidahl K; Söderling AS; Herlitz H; Johannsson G
J Hypertens; 2003 Oct; 21(10):1905-14. PubMed ID: 14508197
[TBL] [Abstract][Full Text] [Related]
47. Concomitant therapies (glucocorticoids and sex hormones) in adult patients with growth hormone deficiency.
Scaroni C; Ceccato F; Rizzati S; Mantero F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):61-5. PubMed ID: 19020389
[TBL] [Abstract][Full Text] [Related]
48. Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy.
Malerba M; Bossoni S; Radaeli A; Mori E; Romanelli G; Tantucci C; Giustina A; Grassi V
Bone; 2006 Jan; 38(1):119-24. PubMed ID: 16154397
[TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of growth hormone replacement therapy in adults.
Toogood A
Expert Opin Drug Saf; 2005 Nov; 4(6):1069-82. PubMed ID: 16255665
[TBL] [Abstract][Full Text] [Related]
50. Muscle strength and power, maximum oxygen consumption, and body composition in middle-aged short-stature adults with childhood-onset growth hormone deficiency.
Sartorio A; Agosti F; De Col A; Mazzilli G; Marazzi N; Busti C; Galli R; Lafortuna CL
Arch Med Res; 2008 Jan; 39(1):78-83. PubMed ID: 18067999
[TBL] [Abstract][Full Text] [Related]
51. Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
Agha A; Walker D; Perry L; Drake WM; Chew SL; Jenkins PJ; Grossman AB; Monson JP
Clin Endocrinol (Oxf); 2007 Jan; 66(1):72-7. PubMed ID: 17201804
[TBL] [Abstract][Full Text] [Related]
52. Two hot topics in the field of GH therapy: quality of life in hypopituitary adults, and clinical implications of the somatopause. Report from an interactive discussion.
Jørgensen JO
J Endocrinol Invest; 1999; 22(5 Suppl):150-6. PubMed ID: 10442585
[No Abstract] [Full Text] [Related]
53. Can growth hormone prevent aging?
Vance ML
N Engl J Med; 2003 Feb; 348(9):779-80. PubMed ID: 12606731
[No Abstract] [Full Text] [Related]
54. [Growth hormone deficiency in adults--clinical picture and treatment].
Christiansen JS; Jørgensen JO; Müller JR; Skakkebaek NE
Ugeskr Laeger; 1995 Jan; 157(4):428-32. PubMed ID: 7846786
[TBL] [Abstract][Full Text] [Related]
55. Growth and hormone deficiency and peak bone mass.
Bouillon R; Prodonova A
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1327-36. PubMed ID: 11202205
[TBL] [Abstract][Full Text] [Related]
56. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.
Carroll PV; Christ ER; Bengtsson BA; Carlsson L; Christiansen JS; Clemmons D; Hintz R; Ho K; Laron Z; Sizonenko P; Sönksen PH; Tanaka T; Thorne M
J Clin Endocrinol Metab; 1998 Feb; 83(2):382-95. PubMed ID: 9467546
[No Abstract] [Full Text] [Related]
57. Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control.
Packer RJ; Boyett JM; Janss AJ; Stavrou T; Kun L; Wisoff J; Russo C; Geyer R; Phillips P; Kieran M; Greenberg M; Goldman S; Hyder D; Heideman R; Jones-Wallace D; August GP; Smith SH; Moshang T
J Clin Oncol; 2001 Jan; 19(2):480-7. PubMed ID: 11208842
[TBL] [Abstract][Full Text] [Related]
58. Clinical effects of growth hormone on bone: a review.
Kann PH
Aging Male; 2004 Dec; 7(4):290-6. PubMed ID: 15799124
[TBL] [Abstract][Full Text] [Related]
59. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement.
Hammarstrand C; Ragnarsson O; Bengtsson O; Bryngelsson IL; Johannsson G; Olsson DS
Eur J Endocrinol; 2018 Oct; 179(4):229-237. PubMed ID: 30299891
[TBL] [Abstract][Full Text] [Related]
60. Growth hormone and growth hormone deficiency--still a lot to learn.
Kiess W; Penke M; Pfäffle R; Körner A; Kratzsch J
J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):971-3. PubMed ID: 26353173
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
